Carbohydrate Metabolism Differs in Infants by Asthma-risk Status and is Associated with the Functional Potential of Bacteroides cellulosilyticus

2.Childhood atopic disease is linked to delayed gut microbiome development and metabolic dysfunction, however microbial drivers remain unclear. To explore microbial correlates of asthma risk during a time of active gut microbiome development, we analyzed stool from 6-month-old infants at high asthma risk (HR) or healthy controls (HC), using Genome-resolved metagenomics (HR=7; HC=12) and untargeted metabolomics (HR=11; HC=15). We recovered 82 bacterial species-level metagenomic-assembled genomes (MAGs). Global Taxonomic composition did not differ by asthma risk. Anticipating that key differences might associate with specific genomes, a machine-learning approach pinpointed Bacteroides cellulosilyticus, Hungatella effluvii, and Enterocloster aldenensis as linked with asthma risk status. All three species were more abundant in HC infants and the B. cellulosilyticus genome was enriched for carbohydrate metabolism genes relative to other MAGs. Metabolomic profiling revealed variance associated with asthma risk (PERMANOVA, R2 =0.069, p=0.016). HR fecal metabolomes were enriched in simple sugars, whereas HC contained more nitrogenous compounds. Integrative genome-metabolic modeling of compounds that significantly differentiate asthma-risk groups revealed risk-dependent interactions with community-encoded metabolic potential (CEP), for arabinose and agmatine, whose fecal concentrations are linked with B. cellulosilyticus and H. effluvii functional traits respectively. These findings suggest that microbial-influenced metabolic differences associate with asthma risk at 6 months, with B. cellulosilyticus and H. effluvii emerging as candidate bacteria influencing this observed metabolic remodeling. 3. Impact statementLeveraging a random forest classifier, we identified three bacterial species (Bacteroides cellulosilyticus, Hungatella effluvii, and Enterocloster aldenensis) as distinguishing features enriched in healthy 6-month old infant microbiomes compared to those at high risk of asthma development (HR). We developed an approach to integrate metabolomics and metagenomic-derived microbiome community encoded potential (CEP) with clinical outcomes to identify fecal metabolites whose concentrations are likely to be influenced by the microbiome. Fecal arabinose concentrations were positively associated with CEP in healthy infants, but not in HR subjects who exhibited elevated concentrations irrespective of CEP. These data implicate microbial activity as a contributor to the concentration of this metabolite in healthy but not HR infants. With a leave-one-out-cross-validation, we identified B. cellulosilyticus as a contributor to fecal arabinose concentrations. Our data indicate that microbial functional deficits in HR infants is associated with altered gut metabolic dysfunction during microbiome maturation. 4. Data summaryDurack et. al [1] is the source of the metabolomics data utilized in this study. The authors confirm that all other supporting data, code and protocols have been provided within the article or through supplementary data files.